FDA
-
-
-
-
-
-
-
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
-
-
-
-
-
-
-
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
-
-
-
-
-
-
-
Lifeward receives shareholder approval for Oramed partnership deal
-
-
-
-
-
-
-
Lifeward completes 1-for-12 reverse share split to meet NASDAQ requirements
-
-
-
-
-
-
-
Lifeward appoints Bob Marshall as board chairman
-
-
-
-
-
-
-
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
-
-
-
-
-
-
-
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
-
334,432 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


